Gordon advised on the sale of Double Helix Bio-Technology Development Ltd, a global provider of market research and market access services to the pharmaceutical and medical device industries, to McCann Health, owned by Interpublic Group.
We are very pleased with this result. After a competitive sale process we identified a buyer who met our client’s price expectations and is the right strategic fit.
.svg)
